1-3 of 3
Chris Jenkins
Close
Sort by
Journal Articles

The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target

Saman Hewamana, Suhair Alghazal, Thet Thet Lin, Matthew Clement, Chris Jenkins, Monica L. Guzman, Craig T. Jordan, Sundar Neelakantan, Peter A. Crooks, Alan K. Burnett, Guy Pratt, Chris Fegan, Clare Rowntree, Paul Brennan, Chris Pepper
Journal: Blood
Blood (2008) 111 (9): 4681–4689.
https://doi.org/10.1182/blood-2007-11-125278
Published: 2008
Journal Articles

Transcription Factor NF-kB as a Biomarker for Disease Progression and Target for Treatment in Chronic Lymphocytic Leukaemia.

Saman Hewamana, MRCP, MRCPath, Mathew Clement, BSc, Thet Thet Lin, PhD, Chris Jenkins, MRCP, Chris Fegan, FRCP,FRCPath,MD, Clare Rowntree, FRCP,MRCPath,PhD, Paul Brennan, PhD, Chris Pepper, PhD
Journal: Blood
Blood (2007) 110 (11): 3091.
https://doi.org/10.1182/blood.V110.11.3091.3091
Published: 2007
Journal Articles

Combination of Gene Expression Data from Myeloid Cell Lines with In Vitro Response to Molecularly Targeted Therapies.

Ken I. Mills, PhD, Amanda F. Gilkes, Beth J. Walsby, PhD, Eleanor L. Woodward, Steve J. Austin, Chris Jenkins, MD, Steven Knapper, MD, Alan K. Burnett, MD
Journal: Blood
Blood (2006) 108 (11): 1361.
https://doi.org/10.1182/blood.V108.11.1361.1361
Published: 2006